WallStreetZenWallStreetZen

NASDAQ: NMTC
Neuroone Medical Technologies Corp Stock

Open Broker Account
$1.63+0.12 (+7.95%)
Updated Dec 5, 2022
NMTC Price
$1.63
Fair Value Price
$2.26
Market Cap
$26.42M
52 Week Low
$0.51
52 Week High
$3.18
P/E
-2.14x
P/B
2.49x
P/S
82.02x
PEG
N/A
Dividend Yield
N/A
Revenue
$162.07k
Earnings
-$11.27M
Gross Margin
-38%
Operating Margin
-6,953.03%
Profit Margin
-6,953%
Debt to Equity
0.09
Operating Cash Flow
-$11M
Beta
0.56
Next Earnings
Dec 13, 2022
Ex-Dividend
N/A
Next Dividend
N/A

NMTC Overview

NeuroOne Medical Technologies Corporation is developing thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other neurological disorders.NeuroOne Medical Technologies was founded in 2015 and is headquartered in Eden Prairie, MN.

Zen Score

Industry Average (32)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how NMTC scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

NMTC ($1.63) is undervalued by 27.83% relative to our estimate of its Fair Value price of $2.26 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
NMTC ($1.63) is significantly undervalued by 27.83% relative to our estimate of its Fair Value price of $2.26 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
NMTC is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more NMTC due diligence checks available for Premium users.

Be the first to know about important NMTC news, forecast changes, insider trades & much more!

NMTC News

Valuation

NMTC fair value

Fair Value of NMTC stock based on Discounted Cash Flow (DCF)
Price
$1.63
Fair Value
$2.26
Undervalued by
27.83%
NMTC ($1.63) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
NMTC ($1.63) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
NMTC is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

NMTC price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-2.14x
Industry
62.76x
Market
21.63x

NMTC price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
2.49x
Industry
3.76x
NMTC is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

NMTC's financial health

Profit margin

Revenue
$32.0k
Net Income
-$2.8M
Profit Margin
-8,611%
NMTC's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
NMTC's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$11.6M
Liabilities
$952.5k
Debt to equity
0.09
NMTC's short-term assets ($10.93M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
NMTC's short-term assets ($10.93M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
NMTC's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
NMTC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$2.6M
Investing
-$54.2k
Financing
$0.0
NMTC's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

NMTC vs Medical Device Stocks

TickerMarket Cap1d %P/EP/B
NMTC$26.42M+7.95%-2.14x2.49x
CFMS$25.78M+2.08%-0.39x0.42x
SIEN$27.67M-3.86%-0.25x-6.39x
DCTH$24.33M-5.67%-0.75x-4.64x
EAR$24.12M+5.52%-0.15x-0.66x

Neuroone Medical Technologies Stock FAQ

What is Neuroone Medical Technologies's quote symbol?

NASDAQ: NMTC) Neuroone Medical Technologies trades on the NASDAQ under the ticker symbol NMTC. Neuroone Medical Technologies stock quotes can also be displayed as NASDAQ: NMTC.

If you're new to stock investing, here's how to buy Neuroone Medical Technologies stock.

What is the 52 week high and low for Neuroone Medical Technologies (NASDAQ: NMTC)?

(NASDAQ: NMTC) Neuroone Medical Technologies's 52-week high was $3.18, and its 52-week low was $0.51. It is currently -48.74% from its 52-week high and 219.61% from its 52-week low.

How much is Neuroone Medical Technologies stock worth today?

(NASDAQ: NMTC) Neuroone Medical Technologies currently has 16,209,232 outstanding shares. With Neuroone Medical Technologies stock trading at $1.63 per share, the total value of Neuroone Medical Technologies stock (market capitalization) is $26.42M.

Neuroone Medical Technologies stock was originally listed at a price of $12.06 in Mar 15, 2018. If you had invested in Neuroone Medical Technologies stock at $12.06, your return over the last 4 years would have been -86.48%, for an annualized return of -39.37% (not including any dividends or dividend reinvestments).

How much is Neuroone Medical Technologies's stock price per share?

(NASDAQ: NMTC) Neuroone Medical Technologies stock price per share is $1.63 today (as of Dec 5, 2022).

What is Neuroone Medical Technologies's Market Cap?

(NASDAQ: NMTC) Neuroone Medical Technologies's market cap is $26.42M, as of Dec 6, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Neuroone Medical Technologies's market cap is calculated by multiplying NMTC's current stock price of $1.63 by NMTC's total outstanding shares of 16,209,232.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.